SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001013594-17-000623
Filing Date
2017-08-09
Accepted
2017-08-09 17:28:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 AUGUST 9, 2017 valeant13d-080917.htm SC 13D 34608
  Complete submission text file 0001013594-17-000623.txt   36397
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45947 | Film No.: 171019031
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020
Business Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020 212-956-2221
PAULSON & CO. INC. (Filed by) CIK: 0001035674 (see all company filings)

IRS No.: 133796759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D